This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
Invivyd Inc. is a biopharmaceutical company whose core business is the development and commercialization of antibody-based therapies. The company’s lead product, PEMGARDA, is a monoclonal antibody therapy for pre-exposure prophylaxis of COVID-19. The development of such biologics typically involves animal testing at multiple stages, including preclinical safety and efficacy studies, as required by regulatory bodies like the U.S. Food and Drug Administration. This places the company’s primary revenue-generating activity within the scope of commercial animal exploitation.
A search of publicly available enforcement databases, including ViolationTracker and the Good Pharma Scorecard, did not return specific records of animal welfare violations for Invivyd. However, the company’s business model is inherently dependent on animal-based research to bring its products to market. The absence of a public commitment to alternative testing methods or a clear policy on the reduction and replacement of animal studies indicates this exploitation is a sustained, material part of its operations.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.